Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 May;25(5):655–656. doi: 10.1128/aac.25.5.655

Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B.

C B Panosian, M Barza, F Szoka, D J Wyler
PMCID: PMC185609  PMID: 6732232

Abstract

The therapeutic efficacy of a liposomal preparation of amphotericin B was evaluated in two murine models of cutaneous leishmaniasis. No significant decrease in tissue parasite density was observed in C57BL/6 mice after systemic treatment instituted seven days after footpad inoculation with Leishmania tropica; in contrast, BALB/c mice showed a modest response.

Full text

PDF
655

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alving C. R., Steck E. A., Chapman W. L., Jr, Waits V. B., Hendricks L. D., Swartz G. M., Jr, Hanson W. L. Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2959–2963. doi: 10.1073/pnas.75.6.2959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beach D. H., Holz G. G., Jr, Anekwe G. E. Lipids of Leishmania promastigotes. J Parasitol. 1979 Apr;65(2):201–216. [PubMed] [Google Scholar]
  3. Black C. D., Watson G. J., Ward R. J. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans R Soc Trop Med Hyg. 1977;71(6):550–552. doi: 10.1016/0035-9203(77)90155-9. [DOI] [PubMed] [Google Scholar]
  4. Graybill J. R., Craven P. C., Taylor R. L., Williams D. M., Magee W. E. Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis. 1982 May;145(5):748–752. doi: 10.1093/infdis/145.2.748. [DOI] [PubMed] [Google Scholar]
  5. Handman E., Ceredig R., Mitchell G. F. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust J Exp Biol Med Sci. 1979 Feb;57(1):9–29. doi: 10.1038/icb.1979.2. [DOI] [PubMed] [Google Scholar]
  6. Lopez-Berestein G., Mehta R., Hopfer R. L., Mills K., Kasi L., Mehta K., Fainstein V., Luna M., Hersh E. M., Juliano R. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis. 1983 May;147(5):939–945. doi: 10.1093/infdis/147.5.939. [DOI] [PubMed] [Google Scholar]
  7. Marsden P. D. Current concepts in parasitology. Leishmaniasis. N Engl J Med. 1979 Feb 15;300(7):350–352. doi: 10.1056/NEJM197902153000706. [DOI] [PubMed] [Google Scholar]
  8. Medoff G., Kobayashi G. S. Strategies in the treatment of systemic fungal infections. N Engl J Med. 1980 Jan 17;302(3):145–155. doi: 10.1056/NEJM198001173020304. [DOI] [PubMed] [Google Scholar]
  9. Neva F. A., Wyler D., Nash T. Cutaneous leishmaniasis--a case with persistent organisms after treatment in presence of normal immune response. Am J Trop Med Hyg. 1979 May;28(3):467–471. [PubMed] [Google Scholar]
  10. New R. R., Chance M. L., Heath S. Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. J Antimicrob Chemother. 1981 Nov;8(5):371–381. doi: 10.1093/jac/8.5.371. [DOI] [PubMed] [Google Scholar]
  11. New R. R., Chance M. L., Thomas S. C., Peters W. Antileishmanial activity of antimonials entrapped in liposomes. Nature. 1978 Mar 2;272(5648):55–56. doi: 10.1038/272055a0. [DOI] [PubMed] [Google Scholar]
  12. Panosian C. B., Wyler D. J. Acquired macrophage resistance to in vitro infection with Leishmania. J Infect Dis. 1983 Dec;148(6):1049–1054. doi: 10.1093/infdis/148.6.1049. [DOI] [PubMed] [Google Scholar]
  13. Peters W. The treatment of kala-azar--new approaches to an old problem. Indian J Med Res. 1981 Jan;73 (Suppl):1–18. [PubMed] [Google Scholar]
  14. Steck E. A. The chemotherapy of protozoal infections of man. J Protozool. 1981 Feb;28(1):10–16. doi: 10.1111/j.1550-7408.1981.tb02796.x. [DOI] [PubMed] [Google Scholar]
  15. Steck E. A. The chemotherapy of protozoal infections: whither? J Protozool. 1981 Feb;28(1):30–35. doi: 10.1111/j.1550-7408.1981.tb02800.x. [DOI] [PubMed] [Google Scholar]
  16. Szoka F., Jr, Papahadjopoulos D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng. 1980;9:467–508. doi: 10.1146/annurev.bb.09.060180.002343. [DOI] [PubMed] [Google Scholar]
  17. Taylor R. L., Williams D. M., Craven P. C., Graybill J. R., Drutz D. J., Magee W. E. Amphotericin B in liposomes: a novel therapy for histoplasmosis. Am Rev Respir Dis. 1982 May;125(5):610–611. doi: 10.1164/arrd.1982.125.5.610. [DOI] [PubMed] [Google Scholar]
  18. Wyler D. J., Liang L. F., Downey E., Krim M. Exogenous interferon administration in experimental leishmaniasis: in vivo and in vitro studies. Am J Trop Med Hyg. 1982 Jul;31(4):740–745. doi: 10.4269/ajtmh.1982.31.740. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES